Observational study of people infected with SARS-Cov-2, treated with amantadine.

Gonzalo Emiliano Aranda-AbreuJosé D Aranda-MartínezRamiro AraújoMaría Elena Hernández-AguilarDeissy Herrera-CovarrubiasFausto Rojas-Durán

Published in: Pharmacological reports : PR (2020)

Amantadine can be used as a viable and cost-effective alternative for treating people with severe acute respiratory syndrome (SARS-Cov-2) on an ambulatory basis, while the vaccine is not available.

Keyphrases

sars cov
respiratory syndrome coronavirus
blood pressure
case report
coronavirus disease
respiratory tract